Clinical Trials Browser

Phase 2/3 × Prostatic Neoplasms × gallium 68 PSMA-11 × Clear all

NCT07209878 2025-10-07

68Ga-PSMA-11 PET Imaging for Diagnosing Prostate Cancer, a Head-to-head Comparison With mpMRI

Phase 2/3 Recruiting

Adenocarcinoma, Prostatic Neoplasms

NCT02673151 2022-01-13

68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment

Phase 2/3 Completed

61 enrolled 10 charts

Prostatic Neoplasms